Osiris and Aastrom: the Best Stem Cell Plays
by Andrew Vaino I’ve resisted recommending stem cell stocks. While I’m still not a huge fan of them, I think it might be worth owning at least one as part of a diversified biotech…
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 387Project BioShield Has Given Biotechs Little Motivation to Protect Americans
by H.S. AyoubBioHealth Investor The anthrax letters that contaminated the U.S. Postal Office system, and the traces of ricin found in congressional buildings had added to the mass hysteria that began on that dark…
Fort Apache For Big Pharma
In a sign that large pharma companies may try cooperating instead of competing as generic drug companies come for their business, AstraZeneca (AZN) and Bristol-Myers (BMY) will jointly market two new diabetes drugs. The…
Send The Stents To Europe, They’ll Try Anything
Boston Scientific (BSX) is beginning to market its new drug-coated stent in Europe. After the firestorm of criticism in the US about whether drug-coated stents can cause clotting and heart problems, maybe launching overseas…
Thursday’s Top Biotech and Medical Stocks
From BioHealth Investor Biotechnology IDERA PHARMACEUTICAL +13.53% RENOVIS INC +10.16% COMBINATORX +9.92% IMMUNE RESPONSE NEW +9.86% HANA BIOSCIENCES INC +8.90% Diagnostic Substances HEALTHCARE TECH LTD +26.40% RG GLBL LIFESTYLS +12.50% MONOGRAM BIOSCIENCES +9.80% ADVANCE…
Genentech 4th Quarter Report Kickstarts Biotech Rally
From BioHealth Investor by H.S. AyoubBioHealth Investor.com Biotech stocks had a great day Thursday as both the Nasdaq (^NBI) and the Amex (^BTK) biotechnology indices were higher by more than 1% each. Genentech (DNA)…
Wednesday’s Top Biotech and Medical Stocks
From BioHealth Investor Biotechnology INSMED INC +22.33% LEV PHARMACEUTICALS +15.11% ACCENTIA BIOPHARMACE +11.39% NEURALSTEM INC +10.17% HEMOBIOTECH INC +8.11% Diagnostic Substances THRESHOLD PHARMACEUT +8.59% REMOTEMDX INC +8.11% PONIARD PHARMA +5.78% ORCHID CELLMARK INC +5.08%…
Cephalon: Rare Biopharmaceutical Value Play for 2007
From BioHealth Investor In December, biopharmaceutical company Cephalon Inc. (CEPH) made the announcement that it has reduced its debt levels by exchanging a combination of cash and stock for $337 million in convertible notes.…
Genomic Health, Insmed Lead as Biotechs Gain
From BioHealth Investor by H.S. AyoubBioHealth Investor.com Both the Nasdaq (^NBI) and Amex (^BTK) biotech stock indices gained on Wednesday as biopharmaceutical and medical device stocks had a generally good day on Wall Street.…
Genetech Reacts to Q4 Earnings
Genentech (DNA) traded up marginally after beating expectations. The company posted $0.61 EPS vs $0.56 estimates and total product sales of $2.053 Billion; revenues were $2.714 Billion versus $2.55 Billion estimates. They forecast 2007…
Tuesday’s Top Biotech and Medical Stocks
From BioHealth Investor Biotechnology INNCARDIO INC +180.00% CYTRX CP +15.56% CRITICAL THERAPEUTIC +13.60% INCYTE CORP +11.01% AMERICAN ORIENTL BIO +10.00% Diagnostic Substances REMOTEMDX INC +12.17% AKORN INC +6.07% HEALTHCARE TECH LTD +4.35% ORCHID CELLMARK…
RNAi developments by Alnylam, CytRx Highlight Tuesday’s Biotech News
by H.S. AyoubBioHealth Investor.com The Nasdaq Biotechnology Index ( ^NBI) gained slightly on Tuesday ending the trading session at $807.34. Alnylam Pharmaceuticals (ALNY) gained almost 9% on the day after the company announced it…
IPO Alert: VeriChip Amended IPO Filing and Backdoor Plays
VeriChip has made an amended filing on its IPO process, and this now looks closer to fruition than it has previously. The company will trade under the ticker "CHIP" on NASDAQ. Underwriters on the…
Monday’s Top Biotech and Medical Stocks
From BioHealth Investor Biotechnology POLYMEDIX INC +60.00% SEATTLE GENETICS I +24.01% CYCLACEL PHARMACEUTI +20.93% INNCARDIO INC +19.05% PIPEX PHARMACEUTICAL +12.78% Diagnostic Substances IMMUNOMEDICS INC +16.85% ICAGEN, INC. +13.57% GENE LOGIC INC +4.24% CYTOGEN CORP…
Biotech Indices Mixed as AMEX Gains, Nasdaq Slips
From BioHealth Investor by H.S. AyoubBioHealth Investor.com The major biotech indices were mixed on Monday. The AMEX Biotechnology Index (^BTK) gained more than 3 points, ending trading at $761.54, while the Nasdaq Biotech Index…